Shares of Target (TGT) are selling at a bit of a discount—but that discount is shrinking. The retailer’s stock was up more than 2% in recent trading. At its current level near $95, Target is still below the price just above $98 at which it closed Tuesday before reporting its latest financial results—but also substantially off the sub-$91 lows it

Target cuts its full-year sales forecast as tariff pressures, weak spending, and backlash over DEI rollbacks weigh on performance and consumer sentiment.

Medical device maker Medtronic plans to separate its diabetes business into a stand-alone company, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.